Chargement en cours...
Elevated Serum Megakaryocyte Potentiating Factor as a Predictor of Poor Survival in Patients with Mesothelioma and Primary Lung Cancer
BACKGROUND: There is an urgent need for a companion assay to work with mesothelin-targeted therapeutic agents and for noninvasive and accurate prognostication of malignant mesothelioma (MM) patients. We report the development and validation of a blood-based assay for megakaryocyte potentiating facto...
Enregistré dans:
| Publié dans: | J Appl Lab Med |
|---|---|
| Auteurs principaux: | , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6201267/ https://ncbi.nlm.nih.gov/pubmed/30370398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1373/jalm.2017.025015 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|